27 DRYDOCK AVENUE, BOSTON, MA
Ginkgo Bioworks Enters Stock Purchase Agreement with Tower Biosecurity
Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
Material disclosure
Reports Third Quarter 2025 Financial Results
News, Underwriting Agreement, Legal Opinion
Other Events
Reports Second Quarter 2025 Financial Results
Shareholder votes
FY 2024
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRER14A
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload